Relevium Technologies (CVE:RLV) Director Pierre Bertrand sold 100,000 shares of the business’s stock in a transaction dated Thursday, April 19th. The stock was sold at an average price of C$0.20, for a total value of C$20,000.00.

Shares of CVE:RLV opened at C$0.22 on Friday. Relevium Technologies has a 1 year low of C$0.09 and a 1 year high of C$0.35.

TRADEMARK VIOLATION NOTICE: This news story was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international trademark & copyright laws. The correct version of this news story can be accessed at

Relevium Technologies Company Profile

Relevium Technologies Inc engages in the identification, evaluation, and acquisition of assets or businesses in the health and wellness markets. It primarily focuses in the areas of e-commerce and wellness services, as well as on nutraceuticals, sports nutrition, and nutri-cosmeceutical products. The company was formerly known as BIOflex Technologies Inc and changed its name to Relevium Technologies Inc in December 2015.

Receive News & Ratings for Relevium Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relevium Technologies and related companies with's FREE daily email newsletter.